685533-95-3

Usage

Class

Substituted aniline
It is a derivative of aniline, which is a basic class of organic compounds used in the production of dyes, pharmaceuticals, and agrochemicals.

Trifluoromethyl group

(CF3)
A fluorinated alkyl group consisting of a carbon atom bonded to three fluorine atoms, which can influence the compound's reactivity, stability, and lipophilicity.

Dimethylaminoethoxy group

(N(CH3)2OCH2)
An alkoxyamine group formed by the attachment of a dimethylamino group (N(CH3)2) to an ethoxy group (OCH2), which can contribute to the compound's solubility and reactivity.
5. Valuable intermediate
2-[2-(DIMETHYLAMINO)ETHOXY]-5-(TRIFLUOROMETHYL)-ANILINE serves as an important building block in the synthesis of various pharmaceuticals and agrochemicals due to its unique functional groups.
6. Health and safety risks
Proper handling and precautions are necessary when working with 2-[2-(DIMETHYLAMINO)ETHOXY]-5-(TRIFLUOROMETHYL)-ANILINE, as it may pose potential hazards to human health and the environment.

Upstream product

• 685533-96-4 C₁₁H₁₃F₃N₂O₃ 

Relevant academic research and scientific papers

BISARYLUREA DERIVATIVES

The present invention relates to bisarylurea derivatives of formula (I), the use of the compounds of formula (I) as inhibitors of raf-kinase, the use of the compounds of formula (I) for the manufacture of a pharmaceutical composition and a method of treatment, comprising administering said pharmaceutical composition to a patient.

ISOQUINOLINE DERIVATIVES

The present invention relates to isoquinoline derivatives of formula (I), the use of the compounds of formula (I), as inhibitors of one or more kinases, the use of the compounds of formula (I), for the manufacture of a pharmaceutical composition and a method of treatment, comprising administering said pharmaceutical composition to a patient.

SEMICARBAZIDE DERIVATIVES AS KINASE INHIBITORS

The present invention relates to semicarbazide derivatives of formula I, the use of the compounds of formula I as inhibitors of one or more kinases, the use of the compounds of formula I for the manufacture of a pharmaceutical composition and a method of treatment, comprising administering said pharmaceutical composition to a patient.

METHYLENE UREA DERIVATIVES

The present invention relates to methylene urea derivatives of formula (I), the use of the compounds of formula (I) as inhibitors of raf-kinase, the use of the compounds of formula (I) for the manufacture of a pharmaceutical composition and a method of treatment, comprising administering said pharmaceutical composition to a patient.